Developing Hydrogels for Bioprinting Astrocytes

A Promising Step Towards 3D Brain Tissue Models

Investigating the human brain

Understanding the human brain remains one of the most prominent branches in science. While scientists have made significant progress, further advancements are hindered due to the lack of effective human brain models. Often, researchers rely on complex 2D co-culture methods or animal models. These can be both expensive and time-consuming, and do not accurately represent the human brain.

Dr. Anna Herland at KTH Royal Institute of Technology and Dr. Daniel Aili from Linköping University recognized the need to enable researchers to develop more biomemitic models of sophisticated brain-like structures such as the brain-blood-barrier (BBB) and the central nervous system. The BBB plays a crucial role in filtering compounds in the bloodstream. It ensures the brain tissues are supplied with nutrients, hormones and smaller molecules while being protected from pathogens and harmful particles.

The team has always been fascinated by how cells are affected by different materials and how they interact with each other in the microenvironment and recognized the importance of mimicking the extracellular matrix (ECM) environment to develop accurate 3D models of the BBB. To achieve this, culturing astrocytes in 3D was a critical step.  

Dr. Daniel Aili.
Photographer: Olov Planthaber, Linköping University

The role of astrocytes and the hydrogel they are cultured in

Astrocytes are the most abundant cell type in the brain and have numerous functions. Astrocytes provide structural support to neurons, regulating the levels of chemicals in the extracellular space, and help to form the BBB. They also play a role in the repair and regeneration of damaged neural tissue, and in the modulation of synaptic activity, which is important for learning and memory.

For the researchers, it was important to understand how astrocytes are affected by the materials they are cultured in. The close collaboration between the team of Dr. Anna Herland and Dr. Daniel Aili led them to develop a modular and bioprintable hydrogel system that could mimic key aspects of the ECM and would allow for tuning interactions between fetal primary astrocytes and the hyaluronan (HA) based hydrogels.  

The hydrogels contained peptide cell adhesion motifs, cRGD and IKVAV. These motifs were chosen as the have been shown to improve cellular attachment in synthetic ECM models. Furthermore, they increase the ability of cells to differentiate into neurons and promote growth of branches.

Engineering hydrogels for astrocytes with bioprinting

The objective of the team was to create a hydrogel for neuron-like cells, specifically astrocytes, that is suitable for advanced biofabrication methods such as bioprinting. This would enable the creation of more intricate 3D models with precise structures and control over the composition and distribution of hydrogel and cells. One of the driving forces to develop engineered hydrogels as opposed to biologically derived hydrogel matrices, was to enable more reproducible experiments. Synthetic hydrogels allow for better control over the behaviour of cells and ensures consistency of the bioink.

To ensure the possibility to use an astrocyte-laden hydrogel as a bioink for bioprinting, Dr. Aili leveraged the BIO X and a syringe printhead. The team printed structures in a grid pattern and analyzed the cell number and morphology.

After optimizing the hydrogel system, the team confirmed it prints with good resolution despite being a softer biomaterial. It also remained stable and supported cell growth. The team observed high cell viability during and after the printing process and that the stress incurred by the cells was minimal.

“The printing process was very straightforward. The only factor we were not sure about was how the astrocytes will tolerate the bioprinting process. We saw a large difference based on what hydrogel composition we used. But with the right hydrogel composition, the cells did great.”

A key step toward replicating the complexity of structures in the brain

During a 6-day experiment, it was observed that printing astrocytes using the HA-based hydrogels enabled the cells to spread out their branches and connect to nearby cells in a pattern that forms a network. The specially designed hydrogels enabled the astrocytes to be printed, grown, and maintained. This breakthrough creates the potential to start replicating the intricate composition and spatial complexity of structures in the brain. Which is crucial for developing more advanced brain tissue and disease models. 

Applications in neuroscience

The group’s work has promising applications in neuroscience. 3D models of the BBB can answer fundamental questions. For example, in drug development 3D models would provide a tool to study and better understand how drugs can permeate the BBB.

The team plans to continue collaborating to develop models for both healthy and disease tissues, and also work closely with clinicians. Input and participation from clinicians are key to success and to ensure the research questions being asked are relevant.

Bioprinting creates the opportunity to study more fascinating questions

For nearly 5 years, Dr. Aili’s research group has been utilizing the BIO X bioprinter. According to Dr. Aili, having access to the bioprinter aligns well with his group’s research focus.

"The access to the bioprinter has allowed us to ask more interesting research questions, and has enabled us to be able to do our current research."

Any advice?

We had the opportunity to ask Dr. Aili for advice to scientists who would like to integrate bioprinting into their research. He encouraged researchers to take the leap and try bioprinting. However, he also emphasized the importance of having a deep understanding of both the materials and cellular systems involved. 

Dr. Aili suggested that bringing together a diverse group of individuals with varying backgrounds and knowledge is crucial in this field.

"Go for it."

More Customer Spotlights

Innovative Silk Bioink for 3D Bioprinted Bone Marrow Tissue Models

There is a rising need of platelet units, which is primarily sourced from healthy donors. However, the natural production of platelets coupled with the brief shelf life does not meet the demand by the healthcare industry. Prof. Alessandra Balduini and her team at the University of Pavia are taking this challenge head-on by initiating the EIC Transition SILKink project, which aims to produce a groundbreaking platform that combines the use of natural silk and 3D bioprinting to recreate the environment of the human bone marrow where platelets are produced.

Bioprinting pediatric heart valves that stand the test of time

Heart valve disease is a significant global health issue, affecting millions of people and contributing to a substantial number of cardiovascular-related deaths. Traditional mechanical replacements, while life-saving, present several challenges, especially over time. Most mechanical valves do not grow or adapt with the patient’s body, leading to the need for multiple invasive surgeries. This not only poses inherent risks but also significantly impacts the patient’s quality of life. Issues such as blood clots, calcification, and severe inflammation further complicate the situation. These challenges become even more critical in pediatric cases, where conventional solutions, while still life-saving, may reduce life expectancy by up to 50%. Professor Savoji, Arman Jafari, a PhD student in his lab, and a dedicated team at the University of Montreal have employed bioprinting and their BIO X6 to address these challenges and develop a method to bioprint heart valve replacements.

Empowering Highly Motivated Researchers

We have interviewed Takaaki Arahira, the Associate Professor of the Department of Information Networks, Faculty of Management and Information Sciences at Kyushu Institute of Information Sciences.

Smart Biomaterials: Revolutionizing Drug Delivery

With so many disadvantages having the potential to severely undermine the successful outcome of the therapy, there is an immense requirement, driven by a fusion of both need and convenience, for biomaterials that operate autonomously and intelligently, effectively eliminating the need for human micromanagement. Professor Jeff Bates and his team at the University of Utah are taking this challenge head on. We spoke to Ashwin Velraj, PhD student in Professor Bates’ lab.